Reviva Pharmaceuticals Holdings, Inc.

RVPH · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$30-$39-$24-$9
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$2$3$0$0
Change in WC-$5$7$9-$1
Other Non-Cash-$1$0-$4-$2
Operating Cash Flow-$34-$28-$19-$11
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$23$27$8$31
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$6$0$0
Financing Cash Flow$24$33$8$32
Forex Effect$0$0$0$0
Net Chg. in Cash-$10$5-$11$21
Supplemental Information
Beg. Cash$23$19$30$9
End Cash$13$23$19$30
Free Cash Flow-$34-$28-$19-$11